Literature DB >> 31366540

Prognostic Value of DEPDC1 Expression in Tumor and Non-tumor Tissue of Patients With Hepatocellular Carcinoma.

Masataka Amisaki1, Takuki Yagyu2, E I Uchinaka2, Masaki Morimoto2, Takehiko Hanaki2, Joji Watanabe2, Naruo Tokuyasu2, Teruhisa Sakamoto2, Soichiro Honjo2, Yoshiyuki Fujiwara2.   

Abstract

BACKGROUND/AIM: To evaluate the impact of DEPDC1 expression on patient prognosis after hepatic resection for hepatocellular carcinoma (HCC). PATIENTS AND METHODS: We reviewed data from 75 patients who underwent hepatic resection for HCC between 2004 and 2013. Recurrence at 2 years following resection, which mainly included metastatic recurrence, was defined as late recurrence.
RESULTS: DEPDC1 was up-regulated in HCC tissue and in non-tumor tissue of patients with HCC compared to normal liver (p<0.01 and p<0.01, respectively). High expression of DEPDC1 was associated with poor overall, disease-specific, and disease-free survival (p=0.02, p<0.01, and p<0.01, respectively). High DEPDC1 expression was an independent predictor of death and recurrence (p=0.03 and p<0.01, respectively). High expression of DEPDC1 in non-tumor liver was an independent risk factor for late recurrence (p=0.04).
CONCLUSION: High expression of DEPDC1 in tumor tissue appears to be associated with tumor progression and poor prognosis. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  DEPDC1; liver surgery; risk factor

Mesh:

Substances:

Year:  2019        PMID: 31366540     DOI: 10.21873/anticanres.13614

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

Review 1.  Is the Rationale of Anatomical Liver Resection for Hepatocellular Carcinoma Universally Adoptable? A Hypothesis-Driven Review.

Authors:  Young-Jen Lin; Cheng-Maw Ho
Journal:  Medicina (Kaunas)       Date:  2021-02-02       Impact factor: 2.430

2.  Identification of Key Genes Associated With the Process of Hepatitis B Inflammation and Cancer Transformation by Integrated Bioinformatics Analysis.

Authors:  Jingyuan Zhang; Xinkui Liu; Wei Zhou; Shan Lu; Chao Wu; Zhishan Wu; Runping Liu; Xiaojiaoyang Li; Jiarui Wu; Yingying Liu; Siyu Guo; Shanshan Jia; Xiaomeng Zhang; Miaomiao Wang
Journal:  Front Genet       Date:  2021-09-01       Impact factor: 4.599

3.  Artemisia argyi Essential Oil Inhibits Hepatocellular Carcinoma Metastasis via Suppression of DEPDC1 Dependent Wnt/β-Catenin Signaling Pathway.

Authors:  Yanli Li; Yang Tian; Wei Zhong; Ning Wang; Yafeng Wang; Yan Zhang; Zhuangli Zhang; Jianbo Li; Fang Ma; Zhihong Zhao; Youmei Peng
Journal:  Front Cell Dev Biol       Date:  2021-06-29

4.  [DEPDC1 is Highly Expressed in Lung Adenocarcinoma and Promotes Tumor Cell Proliferation].

Authors:  Jian Shen; Mengmeng Xi
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-06-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.